CFTR inhibition by glibenclamide requires a positive charge in cytoplasmic loop three

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 10, 2007, Pages 2438-2446

  Melin, Patricia ^a   Hosy, Eric ^b   Vivaudou, Michel ^b   Becq, Frédéric ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b CEA GRENOBLE   (France)

Author keywords

CFTR chloride channel; Cystic Fibrosis; cytoplasmic loop three; Glibenclamide; Site of action

Indexed keywords

FORSKOLIN; GLIBENCLAMIDE; HALIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CHLORIDE CURRENT; DRUG SELECTIVITY; DRUG SENSITIVITY; ELECTROPHYSIOLOGY; MUTATION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOPLASM; GLYBURIDE; HUMANS; MUTATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 35148857724     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.05.013     Document Type: Article

References (43)

1. Dean M., and Allikmets R. Evolution of ATP-binding cassette transporter genes. Curr. Opin. Genet. Dev. 5 (1995) 779-785
2. Higgins C.F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8 (1992) 67-113
3. Childs S., and Ling V. The MDR superfamily of genes and its biological implications. Important Adv. Oncol. (1994) 21-36
4. Dean M., and Annilo T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu. Rev. Genomics. Hum. Genet. 6 (2005) 123-142
5. Gadsby D.C., and Nairn A.C. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol. Rev. 79 (1999) S77-S107
6. Yabuuchi H., Takayanagi S., Yoshinaga K., Taniguchi N., Aburatani H., and Ishikawa T. ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochem. Biophys. Res. Commun. 299 (2002) 410-417
7. Golstein P.E., Boom A., van Geffel J., Jacobs P., Masereel B., and Beauwens R. P-glycoprotein inhibition by glibenclamide and related compounds. Pflugers Arch. 437 (1999) 652-660
8. Sheppard D.N., and Welsh M.J. Effect of ATP-sensitive K+channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J. Gen. Physiol. 100 (1992) 573-591
9. Aguilar-Bryan L., Nichols C.G., Wechsler S.W., Clement J.P., Boyd III A.E., Gonzalez G., Herrera-Sosa H., Nguy K., Bryan J., and Nelson D.A. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268 (1995) 423-426
10. Inagaki N., Gonoi T., Clement J.P., Wang C.Z., Aguilar-Bryan L., Bryan J., and Seino S. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 16 (1996) 1011-1017
11. Klein M., Perfus-Barbeoch L., Frelet A., Gaedeke N., Reinhardt D., Mueller-Roeber B., Martinoia E., and Forestier C. The plant multidrug resistance ABC transporter AtMRP5 is involved in guard cell hormonal signalling and water use. Plant J. 33 (2003) 119-129
12. Klokouzas A., Wu C.P., van Veen H.W., Barrand M.A., and Hladky S.B. cGMP and glutathione-conjugate transport in human erythrocytes. Eur. J. Biochem. 270 (2003) 3696-3708
13. Gedeon C., Behravan J., Koren G., and Piquette-Miller M. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta 27 (2006) 1096-1102
14. Payen L., Delugin L., Courtois A., Trinquart Y., Guillouzo A., and Fardel O. The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells. Br. J. Pharmacol. 132 (2001) 778-784
15. Gribble F.M., Ashfield R., Ammala C., and Ashcroft F.M. Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes. J. Physiol. 498 Pt 1 (1997) 87-98
16. Gros L., Virsolvy A., Salazar G., Bataille D., and Blache P. Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel. Biochem. Biophys. Res. Commun. 257 (1999) 766-770
17. Ashfield R., Gribble F.M., Ashcroft S.J., and Ashcroft F.M. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes 48 (1999) 1341-1347
18. Mikhailov M.V., and Ashcroft S.J. Interactions of the sulfonylurea receptor 1 subunit in the molecular assembly of beta-cell K(ATP) channels. J. Biol. Chem. 275 (2000) 3360-3364
19. Mikhailov M.V., Mikhailova E.A., and Ashcroft S.J. Molecular structure of the glibenclamide binding site of the beta-cell K(ATP) channel. FEBS Lett. 499 (2001) 154-160
20. Mikhailov M.V., Mikhailova E.A., and Ashcroft S.J. Structure-function relationships in the beta-cell K(ATP) channel. Biochem. Soc. Trans. 30 (2002) 323-327
21. Hwang T.C., and Sheppard D.N. Molecular pharmacology of the CFTR Cl-channel. Trends Pharmacol. Sci. 20 (1999) 448-453
22. Zhang Z.R., Zeltwanger S., and McCarty N.A. Steady-state interactions of glibenclamide with CFTR: evidence for multiple sites in the pore. J. Membr. Biol. 199 (2004) 15-28
23. Sheppard D.N., and Robinson K.A. Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl-channels expressed in a murine cell line. J. Physiol. 503 Pt 2 (1997) 333-346
24. Schultz B.D., DeRoos A.D., Venglarik C.J., Singh A.K., Frizzell R.A., and Bridges R.J. Glibenclamide blockade of CFTR chloride channels. Am. J. Physiol. 271 (1996) L192-L200
25. Aubin C.N., and Linsdell P. Positive charges at the intracellular mouth of the pore regulate anion conduction in the CFTR chloride channel. J. Gen. Physiol. 128 (2006) 535-545
26. Ge N., Muise C.N., Gong X., and Linsdell P. Direct comparison of the functional roles played by different transmembrane regions in the cystic fibrosis transmembrane conductance regulator chloride channel pore. J. Biol. Chem. 279 (2004) 55283-55289
27. Linsdell P. Location of a common inhibitor binding site in the cytoplasmic vestibule of the cystic fibrosis transmembrane conductance regulator chloride channel pore. J. Biol. Chem. 280 (2005) 8945-8950
28. St. Aubin C.N., Zhou J.J., and Linsdell P. Identification of a second blocker binding site at the cytoplasmic mouth of the CFTR chloride channel pore. Mol. Pharmacol. 71 (2007) 1360-1368
29. Seibert F.S., Linsdell P., Loo T.W., Hanrahan J.W., Riordan J.R., and Clarke D.M. Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity. J. Biol. Chem. 271 (1996) 27493-27499
30. Moyer B.D., Loffing J., Schwiebert E.M., Loffing-Cueni D., Halpin P.A., Karlson K.H., Ismailov II, Guggino W.B., Langford G.M., and Stanton B.A. Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in Madin-Darby canine kidney cells. J. Biol. Chem. 273 (1998) 21759-21768
31. Liman E.R., Tytgat J., and Hess P. Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron 9 (1992) 861-871
32. Melin P., Thoreau V., Norez C., Bilan F., Kitzis A., and Becq F. The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein. Biochem. Pharmacol. 67 (2004) 2187-2196
33. Melin P., Norez C., Callebaut I., and Becq F. The glycine residues G551 and G1349 within the ATP-binding cassette signature motifs play critical roles in the activation and inhibition of cystic fibrosis transmembrane conductance regulator channels by phloxine B. J. Membr. Biol. 208 (2005) 203-212
34. Prost A.L., Bloc A., Hussy N., Derand R., and Vivaudou M. Zinc is both an intracellular and extracellular regulator of KATP channel function. J. Physiol. 559 (2004) 157-167
35. Cai Z., Scott-Ward T.S., and Sheppard D.N. Voltage-dependent gating of the cystic fibrosis transmembrane conductance regulator Cl-channel. J. Gen. Physiol. 122 (2003) 605-620
36. Linsdell P. Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. Exp. Physiol. 91 (2006) 123-129
37. Dorschner H., Brekardin E., Uhde I., Schwanstecher C., and Schwanstecher M. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Mol. Pharmacol. 55 (1999) 1060-1066
38. Dawson R.J., and Locher K.P. Structure of a bacterial multidrug ABC transporter. Nature 443 (2006) 180-185
39. Gong X., and Linsdell P. Molecular determinants and role of an anion binding site in the external mouth of the CFTR chloride channel pore. J. Physiol. 549 (2003) 387-397
40. Liu X., Smith S.S., and Dawson D.C. CFTR: what's it like inside the pore?. J. Exp. Zool., A Comp. Exp. Biol. 300 (2003) 69-75
41. Meyer M., Chudziak F., Schwanstecher C., Schwanstecher M., and Panten U. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes. Br. J. Pharmacol. 128 (1999) 27-34
42. Gribble F.M., Tucker S.J., Seino S., and Ashcroft F.M. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes 47 (1998) 1412-1418
43. Bryan J., Crane A., Vila-Carriles W.H., Babenko A.P., and Aguilar-Bryan L. Insulin secretagogues, sulfonylurea receptors and K(ATP) channels. Curr. Pharm. Des. 11 (2005) 2699-2716